Florence Nightingale Hospitals Limited 01431836 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is the operation of a private hospital supplying psychiatric and related treatments Digita Accounts Production Advanced 6.30.9574.0 true true true true true true true true false true 01431836 2024-01-01 2024-12-31 01431836 2024-12-31 01431836 bus:Director10 2024-12-31 01431836 bus:Director12 2024-12-31 01431836 bus:OrdinaryShareClass1 2024-12-31 01431836 bus:Consolidated 2024-12-31 01431836 core:CapitalContributionReserve 2024-12-31 01431836 core:RetainedEarningsAccumulatedLosses 2024-12-31 01431836 core:ShareCapital 2024-12-31 01431836 core:CurrentFinancialInstruments 2024-12-31 01431836 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 01431836 core:CurrentFinancialInstruments core:WithinOneYear 2 2024-12-31 01431836 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 01431836 core:BetweenTwoFiveYears 2024-12-31 01431836 core:MoreThanFiveYears 2024-12-31 01431836 core:WithinOneYear 2024-12-31 01431836 core:FurnitureFittingsToolsEquipment 2024-12-31 01431836 core:OtherPropertyPlantEquipment 2024-12-31 01431836 bus:FRS102 2024-01-01 2024-12-31 01431836 bus:Audited 2024-01-01 2024-12-31 01431836 bus:FullAccounts 2024-01-01 2024-12-31 01431836 bus:RegisteredOffice 2024-01-01 2024-12-31 01431836 bus:Director10 2024-01-01 2024-12-31 01431836 bus:Director11 2024-01-01 2024-12-31 01431836 bus:Director12 2024-01-01 2024-12-31 01431836 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 01431836 bus:Consolidated 2024-01-01 2024-12-31 01431836 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 01431836 bus:Agent1 2024-01-01 2024-12-31 01431836 core:ComputerSoftware 2024-01-01 2024-12-31 01431836 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 01431836 core:LandBuildingsUnderOperatingLeases 2024-01-01 2024-12-31 01431836 core:PlantEquipmentUnderOperatingLeases 2024-01-01 2024-12-31 01431836 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 01431836 core:LeaseholdImprovements 2024-01-01 2024-12-31 01431836 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 01431836 core:UKTax 2024-01-01 2024-12-31 01431836 1 2024-01-01 2024-12-31 01431836 1 2024-01-01 2024-12-31 01431836 countries:EnglandWales 2024-01-01 2024-12-31 01431836 2023-12-31 01431836 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 01431836 core:FurnitureFittingsToolsEquipment 2023-12-31 01431836 core:OtherPropertyPlantEquipment 2023-12-31 01431836 2023-01-01 2023-12-31 01431836 2023-12-31 01431836 bus:OrdinaryShareClass1 2023-12-31 01431836 core:CapitalContributionReserve 2023-12-31 01431836 core:RetainedEarningsAccumulatedLosses 2023-12-31 01431836 core:ShareCapital 2023-12-31 01431836 core:CurrentFinancialInstruments 2023-12-31 01431836 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 01431836 core:CurrentFinancialInstruments core:WithinOneYear 2 2023-12-31 01431836 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 01431836 core:BetweenTwoFiveYears 2023-12-31 01431836 core:MoreThanFiveYears 2023-12-31 01431836 core:WithinOneYear 2023-12-31 01431836 core:FurnitureFittingsToolsEquipment 2023-12-31 01431836 core:OtherPropertyPlantEquipment 2023-12-31 01431836 core:LandBuildingsUnderOperatingLeases 2023-01-01 2023-12-31 01431836 core:PlantEquipmentUnderOperatingLeases 2023-01-01 2023-12-31 01431836 core:UKTax 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 01431836

Florence Nightingale Hospitals Limited

Annual Report and Financial Statements

for the Year Ended 31 December 2024

 

Florence Nightingale Hospitals Limited

Contents

Company Information

1

Strategic Report

2 to 4

Directors' Report

5 to 6

Statement of Directors' Responsibilities

7

Independent Auditor's Report

8 to 11

Statement of Income and Retained Earnings

12

Statement of Financial Position

13

Notes to the Financial Statements

14 to 24

 

Florence Nightingale Hospitals Limited

Company Information

Directors

A Opoku

J E Williams

Registered office

11-19 Lisson Grove
London
NW1 6SH

Independent auditor

Shaw Gibbs (Audit) Limited
Statutory AuditorSalatin House
19 Cedar Road
Sutton
Surrey
SM2 5DA

 

Florence Nightingale Hospitals Limited

Strategic Report for the Year Ended 31 December 2024

The directors present their strategic report on the affairs of Florence Nightingale Hospitals Limited for the year ended 31 December 2024.

Fair review of the business

The company's principal activity during the year continued to be the operation of a private hospital supplying psychiatric and related treatments.

There have been several challenges during the year to 31 December 2024, most significantly the recruitment of nurses (of all grades) and clinical staff as a result of the national shortage. Premium rates had to be paid for the resources available to deliver essential care for the patients. Thus consequently leading to a high increase in the cost of labour. This significantly impacted the profitability of the business and has been reflected in the results to 31 December 2024.

The business has embarked on a major recruitment drive and has been engaging with universities to attract staff for training and internship opportunities, during which they will learn and gain practical knowledge in supplying psychiatric and related treatments. In addition, the business has launched various recruitment initiatives to attract nurses to the psychiatric care sector and results of the initiatives are being seen in the second quarter of the year to 31 December 2024.

The company's key financial and other performance indicators during the year were as follows:

Financial KPIs

Unit

2024

2023

Turnover

£

24,170,853

23,703,752

Operating profit/(loss)

£

(449,981)

133,770

Proft/(loss) after tax

£

(468,584)

323,729

Total number of beds (Operational)

73

73

Bed Occupancy

%

61

50

Average number of employees (Including temporary staff)

262

249

Principal risks and uncertainties

• Competitive risks
The company is reliant on the number of predominantly non-contracted patient referrals it receives from private referrers. The level of patient referrals is therefore uncertain.

• Pricing levels
Pricing remains competitive with self-paying increases held in line with inflationary levels seen within the reported period. Private medical insurance pricing has become less stable and subject to aggressive renegotiations as widely reported across the healthcare sector.

• Liquidity and cash flow
Trading growth and a lowered cost base has improved the company’s liquidity. The company is free of debt or liabilities outside of standard trade creditors.

• Legislative risks
The psychiatric services performed by the company must comply with Care Standards Act 2000 and Mental Health Act 2007. These standards are subject to continuous revision and any material changes could significantly impact service delivery and in turn the company’s financial results.

 

Florence Nightingale Hospitals Limited

Strategic Report for the Year Ended 31 December 2024 (continued)

Future developments

The services offered at the hospital have been expanded to reflect innovative changes in mental health delivery.

The hospital continues to adapt the operational model in order it meets the regulatory requirements.

Non-financial and sustainability information

Employment of disabled persons

The company gives full consideration to applications for employment from disabled persons where a handicapped or disabled person's particular aptitudes and abilities are consistent with adequately fulfilling the requirements of the job. Where existing employees become disabled, the company's policy wherever practicable is to provide continuing employment in the same or an alternative position and to provide appropriate training to achieve this aim. Opportunities for training, career development and promotion do not operate to the detriment of disabled employees.

Employee involvement

During the financial year, the following actions have been taken to introduce, maintain, and develop arrangements aimed at:

(i) Providing employees systematically with information on matters of concern to them as employees:
The company has in place regular channels of communication including team briefings, departmental meetings, newsletters, and updates via the intranet. These ensure that employees are kept informed about developments within the hospital, operational performance, quality and safety matters, and any other issues affecting their roles.

(ii) Consulting employees or their representatives on a regular basis so that the views of employees can be considered in making decisions which are likely to affect their interests:
The hospital actively engages with employee representatives through formal consultative committees. In addition, regular staff surveys are conducted to gather feedback and measure employee sentiment, the results of which are considered by the management team when making operational or strategic decisions.

(iii) Encouraging the involvement of employees in the company’s performance through an employees’ share scheme or by some other means:
Although there is currently no employee share scheme in place, the hospital recognises and rewards employee contributions through various recognition programmes and performance-related incentive schemes appropriate to the healthcare sector. This includes initiatives to celebrate outstanding staff performance and to acknowledge team and individual achievements.

(iv) Achieving a common awareness on the part of all employees of the financial and economic factors affecting the performance of the company:
Key financial and operational performance indicators are shared with employees through internal communications and staff briefings. Where appropriate, presentations by senior management are arranged to explain the financial position of the company and the wider economic context in which the hospital operates, supporting employees’ understanding of how their roles contribute to the hospital’s objectives and sustainability.

 

Florence Nightingale Hospitals Limited

Strategic Report for the Year Ended 31 December 2024 (continued)

The directors remain committed to fostering a positive and collaborative working environment that supports staff engagement and development at all levels of the organisation.

Approved and authorised by the Board on 23 June 2025 and signed on its behalf by:
 

.........................................
J E Williams
Director

 

Florence Nightingale Hospitals Limited

Directors' Report for the Year Ended 31 December 2024

The directors present their report on the affairs of Florence Nightingale Hospitals Limited, together with the financial statements and the independent auditor's report for the year ended 31 December 2024.

Principal activity

The principal activity of the company is the operation of a private hospital supplying psychiatric and related treatments

Directors of the company

The directors who held office during the year and up to the date of approval of this report were as follows:

A Hussain (resigned 25 March 2025)

A Opoku

The following director was appointed after the year end:

J E Williams (appointed 25 March 2025)

Dividends

The directors have not recommend the payment of a dividend in respect of the financial year ended 31 December 2024 (2023: £Nil).

Information included in the Strategic Report

In accordance with s. 414C(11) of the Companies Act 2006, the company has chosen to include certain information in the strategic report as follows:
• Review of business and future development;
• Principal risks and uncertainties; and
• Policy regarding the hiring, continuing employment and training, career development and promotion of disabled employees.
• Statement outlining actions taken during the financial year to inform, consult, and engage employees, promote their involvement in the company's performance, raise awareness of financial factors affecting the business, and summarise how directors have considered and acted on employee interests in key decisions.

Going concern

The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis in preparing the annual financial statements.

Events after the financial period

There have been no significant events between the year end and the date of approval of these accounts which would require a change to, or disclosure in, the financial statements.

Directors' liabilities

The directors have the benefit of the indemnity provisions and the company has maintained throughout the year directors' and officers' liability insurance for the benefit of the company, the directors and its officers. The company has entered into qualifying third party indemnity arrangements for the benefit of all its directors in a form and scope which comply with the requirements of the Companies Act 2006 and which were in force throughout the year and remain in force.

 

Florence Nightingale Hospitals Limited

Directors' Report for the Year Ended 31 December 2024 (continued)

Disclosure of information to the auditors

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information (as defined by section 418 of the Companies Act 2006) and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Reappointment of auditors

The auditors Shaw Gibbs (Audit) Limited are deemed to be reappointed under section 487(2) of the Companies Act 2006.

Approved and authorised by the Board on 23 June 2025 and signed on its behalf by:
 

.........................................
J E Williams
Director

 

Florence Nightingale Hospitals Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law),including FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Florence Nightingale Hospitals Limited

Independent Auditor's Report to the Member of
Florence Nightingale Hospitals Limited

Opinion

We have audited the financial statements of Florence Nightingale Hospitals Limited (the 'company') for the year ended 31 December 2024, which comprise the Statement of Income and Retained Earnings, Statement of Financial Position, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

Florence Nightingale Hospitals Limited

Independent Auditor's Report to the Member of
Florence Nightingale Hospitals Limited (continued)

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities [set out on page 7], the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

 

Florence Nightingale Hospitals Limited

Independent Auditor's Report to the Member of
Florence Nightingale Hospitals Limited (continued)

The extent to which the audit was considered capable of detecting irregularities including fraud

 

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations. We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements;

we focused on specific laws and regulations which we considered may have a direct material effect on the determination of material amounts and disclosures the financial statements or the operations of the company, including the Companies Act 2006, the Care Standards Act 2000, the Mental Health Act 2007, The Care Quality Commission (Registration) Regulations 2009 (CQC), the Health and Social Care Act 2008, The Equality Act 2010, General Data Protection Rules (GDPR), taxation legislation, employment law and health and safety legislation. We also considered and identified laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty, including the Bribery Act and the Data Protection Act 2018;

we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal and regulatory correspondence;

identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

 

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and

considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

 

We are also required to perform specific procedures to respond to the risk of management bias and override of controls. To address this, we performed analytical procedures to identify any unusual or unexpected relationships; tested journal entries to identify unusual transactions;

 

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

agreeing financial statement to disclosures underlying supporting documentation;

enquiring of management as to actual and potential litigation and claims; and

reviewing correspondence with HMRC and CQC, analysing legal costs to ascertain if there have been instances of non-compliance with laws and regulations.

 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

 

Florence Nightingale Hospitals Limited

Independent Auditor's Report to the Member of
Florence Nightingale Hospitals Limited (continued)

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company’s member, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s member those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s member as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
Ransford Agyei-Boamah (Senior Statutory Auditor)
For and on behalf of Shaw Gibbs (Audit) Limited, Statutory Auditor

Salatin House
19 Cedar Road
Sutton
Surrey
SM2 5DA

23 June 2025

 

Florence Nightingale Hospitals Limited

Statement of Income and Retained Earnings
for the Year Ended 31 December 2024

Note

2024
£

2023
£

Revenue

3

24,170,853

23,703,752

Cost of sales

 

(18,893,466)

(17,885,365)

Gross profit

 

5,277,387

5,818,387

Administrative expenses

 

(5,727,368)

(5,684,617)

Operating (loss)/profit

4

(449,981)

133,770

Other interest receivable

 

-

8,118

Interest income from group undertaking

5

-

42,901

Interest payable and similar charges

6

(18,603)

-

(Loss)/profit before tax

 

(468,584)

184,789

Taxation

10

-

138,940

(Loss)/profit for the financial year

 

(468,584)

323,729

Retained earnings brought forward

 

6,584,419

6,260,690

Retained earnings carried forward

 

6,115,835

6,584,419

 

Florence Nightingale Hospitals Limited

(Registration number: 01431836)
Statement of Financial Position as at 31 December 2024

Note

2024
£

2023
£

Non-current assets

 

Intangible assets

11

45,916

-

Property, plant and equipment

12

4,981,670

4,847,371

 

5,027,586

4,847,371

Current assets

 

Inventories

13

156,636

77,147

Receivables

14

5,427,296

4,678,207

Cash at bank and in hand

15

401,993

1,444,464

 

5,985,925

6,199,818

Payables: Amounts falling due within one year

16

(2,587,676)

(2,152,770)

Net current assets

 

3,398,249

4,047,048

Net assets

 

8,425,835

8,894,419

Equity

 

Called up share capital

17

1,510,000

1,510,000

Capital contribution reserve

17

800,000

800,000

Retained earnings

17

6,115,835

6,584,419

Total equity

 

8,425,835

8,894,419

The financial statements of Florence Nightingale Hospitals Limited were approved and authorised for issue by the Board on 23 June 2025 and signed on its behalf by:
 

.........................................

A Opoku
Director

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

1

General information

Florence Nightingale Hospitals Limited (the 'company') is a private company limited by share capital, registered in England and Wales under the Companies Act. The address of the registered office is given on page 1. The nature of the company’s operations and its principal activities are set out in the directors' report on page 2.

2

Accounting policies

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Going concern

The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis in preparing the annual financial statements.

Statement of compliance

The financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" issued by the Financial Reporting Council and in accordance with the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The functional currency of the company is considered to be pounds sterling (£) because that is the currency of the primary economic environment in which the company operates. The financial statements are presented in pounds sterling (£).

Summary of disclosure exemptions

The company meets the definition of a qualifying entity under FRS 102 and has therefore taken advantage of the disclosure exemptions available to it in respect of its separate financial statements. The company is consolidated in the financial statements of its parent, Emeis SA, which may be obtained from https://emeis.com/en/investors-shareholders/financial-information-and-publications. Exemptions have been taken in these separate company financial statements in relation to financial instruments, presentation of a cash flow statement, transactions with group entities and remuneration of key management personnel.

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

2

Accounting policies (continued)

Judgements

There are no critical judgements made by the directors in the process of applying the company’s accounting policies which have the most significant effect on the amounts recognised in the financial statements.

Key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. The following judgements
(apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

(i) Property, plant and equipment
The company establishes a reliable estimate of the useful life of tangible fixed assets; this estimate is based on a variety of factors which may be uncertain. The carrying amount is £4,981,670 (2023: £4,847,371).

(ii) Accounts receivable
Accounts receivable are derived from sales. In order to monitor potential credit losses, an ongoing evaluations of the balances outstanding are performed. An allowance for doubtful debts is maintained for potential credit losses based upon management's assessment of the expected collectability of all accounts receivable. The allowance for doubtful accounts is reviewed periodically to assess the adequacy of the allowance. The actual level of debt collected may differ from the estimated levels of recovery and could impact future operating results positively or negatively. As at 31 December 2024 the company's current trade receivables were £4,629,422 against which £775,171 was provided for.

(iii) Deferred tax
At December 2024, the company had unrelieved tax losses of approximately £5,428,220. No deferred tax asset has been recognised in respect of these tax losses. In the director's opinion, there may not be other future taxable profits/gains against which the tax losses will be relieved and consequently have not recognised any deferred tax asset in respect of these losses.

Revenue recognition

Revenue comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Revenue is recognised as services are provided/delivered and direct expenses are incurred.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into Sterling at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing on the initial transaction dates. Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

2

Accounting policies (continued)

Taxation

The tax expense for the period comprises current and deferred tax. Tax is recognised in the income statement, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Current tax, including UK corporation tax and foreign tax, is provided at amounts expected to be paid
(or recovered) using the tax rates and laws that have been enacted or substantively enacted by the
year end.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are differences between the company's taxable profits and its results as stated in the financial statements that arise from the inclusion of gains and losses in tax assessments in periods different from those in which they are recognised in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that, on the basis of all available evidence, it can be regarded as more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.

Property, plant and equipment

Property, plant and equipment are recorded at historical cost less accumulated depreciation and any provision for impairment. Cost comprises the purchase price together with all expenses directly incurred in bringing the asset to its location and condition ready for use.

Depreciation is provided on all property, plant and equipment, at rates calculated to write off the cost, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Asset class

Depreciation method and rate

Long leasehold improvements

Straight line over 10 to 30 years

Equipment and furnishings

Straight line over 5 to 7 years

Intangible assets

Intangible fixed assets represents computer software which is stated in the statement of financial position at cost, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.

The cost of computer software includes directly attributable incremental costs incurred in their acquisition and installation.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Computer software

Straight line over 5 years

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

2

Accounting policies (continued)

Impairment of assets

At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised immediately in statement of income and retained earnings.

If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and bank current account balances and are
subject to insignificant risk of change in value.

Receivables

Receivables are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of receivables is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables.

Payables

Payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities. Payables are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholder is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

2

Accounting policies (continued)

Defined contribution pension obligation

The company operates a defined contribution pension scheme. Contributions are recognised in the Statement of Income and Retained Earnings in the period in which they become payable.

Financial instruments

The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

3

Revenue

The analysis of the company's Revenue for the year from continuing operations is as follows:

2024
£

2023
£

Provision of services

24,076,360

23,605,893

Rental income

94,493

97,859

24,170,853

23,703,752

In the opinion of the directors, the company's revenue, profit before taxation and net assets are attributable to the company's one principal business in the United Kingdom only and not attributable to classes of business or geographical segments which differ substantially from each other. Consequently, no segmental information has been presented.

4

Operating (loss)/profit

Arrived at after charging

2024
£

2023
£

Depreciation expense

760,121

589,570

Amortisation expense

5,538

-

Foreign exchange losses

-

723

Operating lease expense - property

2,564,145

2,378,272

Operating lease expense - plant and machinery

6,944

11,797

5

Interest receivable and similar income

2024
£

2023
£

Other finance income

-

42,901

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

6

Interest payable and similar expenses

2024
£

2023
£

Interest expense on other finance liabilities

18,603

-

7

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2024
£

2023
£

Wages and salaries

9,053,767

8,488,371

Social security costs

924,884

838,825

Pension costs, defined contribution scheme

381,303

276,026

10,359,954

9,603,222

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2024
No.

2023
No.

Production

188

182

Administration and support

74

67

262

249

8

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
£

2023
£

Remuneration

200,114

176,524

Contributions paid to money purchase schemes

12,539

8,577

212,653

185,101

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

9

Auditors' remuneration

2024
£

2023
£

Audit of the financial statements

24,000

14,500

Other fees to auditors

Other non-audit services

27,865

12,066

10

Taxation

Tax charged/(credited) in the income statement

2024
£

2023
£

Current taxation

UK corporation tax adjustment to prior periods

-

(138,940)

The tax on profit before tax for the year is higher than the standard rate of corporation tax in the UK (2023 - lower than the standard rate of corporation tax in the UK) of 25% (2023 - 23.5%).

The differences are reconciled below:

2024
£

2023
£

(Loss)/profit before tax

(468,584)

184,789

Corporation tax at standard rate

(117,146)

43,425

Decrease in tax from adjustment for prior periods

-

(138,940)

Tax decrease from effect of capital allowances and depreciation

(29,708)

(201,396)

Effect of tax losses

146,854

157,971

Total tax credit

-

(138,940)

Deferred tax

There are £5,712,270 of unused tax losses (2023 - £5,124,853) for which no deferred tax asset is recognised in the statement of financial position.

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

11

Intangible assets

Computer software
 £

Cost

At 1 January 2024

566,255

Additions

51,454

At 31 December 2024

617,709

Amortisation

At 1 January 2024

566,255

Amortisation charge

5,538

At 31 December 2024

571,793

Carrying amount

At 31 December 2024

45,916

At 31 December 2023

-

12

Property, plant and equipment

Equipment & furnishings
 £

Long leasehold improvements
£

Total
£

Cost

At 1 January 2024

1,926,304

6,356,736

8,283,040

Additions

333,458

560,962

894,420

At 31 December 2024

2,259,762

6,917,698

9,177,460

Depreciation

At 1 January 2024

524,885

2,910,784

3,435,669

Charge for the year

222,167

537,954

760,121

At 31 December 2024

747,052

3,448,738

4,195,790

Carrying amount

At 31 December 2024

1,512,710

3,468,960

4,981,670

At 31 December 2023

1,401,419

3,445,952

4,847,371

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

13

Inventories

2024
£

2023
£

Hospital supplies

156,636

77,147

14

Receivables

Current

2024
£

2023
£

Trade receivables

3,854,251

3,296,927

Corporation tax recoverable

14

1,511

Other receivables

53,818

48,941

Prepayments and accrued income

1,519,213

1,330,828

 

5,427,296

4,678,207

15

Cash and cash equivalents

2024
£

2023
£

Cash on hand

2,984

1,885

Cash at bank

399,009

1,442,579

401,993

1,444,464

16

Payables

2024
£

2023
£

Due within one year

Trade payables

1,136,137

751,642

Amounts owed to parent undertaking

694,465

386,823

Social security and other taxes

280,495

307,237

Outstanding defined contribution pension costs

55,255

47,667

Other payables

125,693

309,555

Accruals

295,631

349,846

2,587,676

2,152,770

The amounts owed to parent undertaking disclosed as falling within one year is unsecured, payable on demand and is non-interest bearing.

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

17

Share capital and reserves

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

1,510,000

1,510,000

1,510,000

1,510,000

       

Reserves

The retained earnings reserve represents cumulative profit or losses net of dividends paid and other adjustments.

The capital contribution represents funding from the immediate parent that carries no rights to repayment or control over usage. This reserve forms part of the company's distributable reserves.

18

Pension scheme

Defined contribution pension scheme

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £381,303 (2023 - £276,026).

Contributions totalling £55,255 (2023 - £47,667) were payable to the scheme at the end of the year and are included in payables.

19

Obligations under leases

Operating leases

The total of future minimum lease payments is as follows:

2024
£

2023
£

Not later than one year

2,510,577

2,437,453

Later than one year and not later than five years

10,818,416

10,503,317

Later than five years

49,728,830

52,554,506

63,057,823

65,495,276

The amount of non-cancellable operating lease payments recognised as an expense during the year was £2,437,453 (2023 - £2,378,272).

 

Florence Nightingale Hospitals Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024 (continued)

20

Related party transactions

The company is a wholly owned subsidiary member of its group and has therefore taken advantage of the provisions of Section 33. 1A of FRS 102 the "The Financial Reporting Standard applicable in the UK and Republic of Ireland" not to disclose transactions with entities that are wholly owned members of the the group.

There were no other related party transactions to disclose.

21

Parent and ultimate parent undertaking

The company's immediate parent is Groupe Sinoue SAS, incorporated in France.

 The ultimate parent is Emeis SA, incorporated in France.

 The most senior parent entity producing publicly available financial statements is Emeis SA. These financial statements are available upon request from:
https://emeis.com/en/investors-shareholders/financial-information-and-publications

22

Events after the financial period

There have been no significant events between the year end and the date of approval of these accounts which would require a change to, or disclosure in, the financial statements.